{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:46:14Z","timestamp":1783464374239,"version":"3.55.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR301338"],"award-info":[{"award-number":["NIHR301338"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015362","name":"Amicus Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.hfc.2024.12.006","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T07:45:08Z","timestamp":1738914308000},"page":"257-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Obesity Management for Patients with Coronary Artery Disease and Heart Failure"],"prefix":"10.1016","volume":"21","author":[{"given":"Akheel A.","family":"Syed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safwaan","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Alkhaffaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2024.12.006_bib1","unstructured":"World Health Organization, Obesity and Overweight, 2024, World Health Organization; Geneva. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. (Accessed 29 April 2024)."},{"key":"10.1016\/j.hfc.2024.12.006_bib2","unstructured":"World Health Organization, Regional Office for the Western Pacific, 2000, The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications Australia; Sydney. Available at: https:\/\/iris.who.int\/handle\/10665\/206936. (Accessed 29 April 2024)."},{"key":"10.1016\/j.hfc.2024.12.006_bib3","unstructured":"Centers for Disease Control and Prevention, Adult obesity facts, 2022, Centers for Disease Control and Prevention; Atlanta. Available at: https:\/\/www.cdc.gov\/obesity\/data\/adult.html. (Accessed 29 April 2024)."},{"key":"10.1016\/j.hfc.2024.12.006_bib4","unstructured":"Baker C, Research briefing: obesity statistics, 2023, House of Commons Library; London. Available at: https:\/\/commonslibrary.parliament.uk\/research-briefings\/sn03336\/. (Accessed 29 April 2024)."},{"key":"10.1016\/j.hfc.2024.12.006_bib5","unstructured":"Butland B, Jebb S, Kopelman P, et al, Tackling obesities: future choices \u2013 project report, 2nd edition, 2007, Government Office for Science; London. Available at: https:\/\/www.gov.uk\/government\/collections\/tackling-obesities-future-choices. (Accessed 29 April 2024)."},{"issue":"2","key":"10.1016\/j.hfc.2024.12.006_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41576-021-00414-z","article-title":"The genetics of obesity: from discovery to biology","volume":"23","author":"Loos","year":"2021","journal-title":"Nat Rev Genet"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.006_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/osp4.629","article-title":"Obesity and chronic kidney disease: a current review","volume":"9","author":"Nawaz","year":"2023","journal-title":"Obes Sci Pract"},{"issue":"21","key":"10.1016\/j.hfc.2024.12.006_bib8","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American heart association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2024.12.006_bib9","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1016\/j.orcp.2013.12.005","article-title":"Mechanisms of heart failure in obesity","volume":"8","author":"Ebong","year":"2014","journal-title":"Obes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.hfc.2024.12.006_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamacardio.2024.0615","article-title":"Reversals in the decline of heart failure mortality in the US, 1999 to 2021","volume":"9","author":"Sayed","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hfc.2024.12.006_bib11","doi-asserted-by":"crossref","first-page":"107765","DOI":"10.1016\/j.intimp.2021.107765","article-title":"Interleukin-1 in obesity-related low-grade inflammation: from molecular mechanisms to therapeutic strategies","volume":"96","author":"Ghanbari","year":"2021","journal-title":"Int Immunopharm"},{"issue":"9","key":"10.1016\/j.hfc.2024.12.006_bib12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/oby.2000.86","article-title":"Raised interleukin-6 levels in obese patients","volume":"8","author":"Roytblat","year":"2012","journal-title":"Obes Res"},{"key":"10.1016\/j.hfc.2024.12.006_bib13","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3389\/fimmu.2017.01512","article-title":"Effect of roux-en-Y bariatric surgery on lipoproteins, insulin resistance, and systemic and vascular inflammation in obesity and diabetes","volume":"8","author":"Yadav","year":"2017","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.006_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/1479164119826479","article-title":"Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: small, dense low-density lipoprotein and interleukin-6","volume":"16","author":"Adam","year":"2019","journal-title":"Diabetes Vasc Dis Res"},{"issue":"6","key":"10.1016\/j.hfc.2024.12.006_bib15","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/01.ATV.0000163843.70369.12","article-title":"Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance","volume":"25","author":"Hung","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.006_bib16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/cells9030706","article-title":"Role of c-Jun N-terminal kinase (JNK) in obesity and type 2 diabetes","volume":"9","author":"Yung","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.006_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12929-016-0303-y","article-title":"Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?","volume":"23","author":"Rehman","year":"2016","journal-title":"J\u00a0Biomed Sci"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.006_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0735-1097(97)00494-4","article-title":"Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure","volume":"31","author":"Tsutamoto","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.hfc.2024.12.006_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.03-0331fje","article-title":"Role of interleukin-6 for left ventricular remodeling and survival after experimental myocardial infarction","volume":"17","author":"Fuchs","year":"2003","journal-title":"Faseb J"},{"issue":"5","key":"10.1016\/j.hfc.2024.12.006_bib20","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/01.CIR.91.5.1520","article-title":"Hypoxic stress induces cardiac myocyte\u2013derived interleukin-6","volume":"91","author":"Yamauchi-Takihara","year":"1995","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hfc.2024.12.006_bib21","doi-asserted-by":"crossref","first-page":"e012638","DOI":"10.1161\/JAHA.119.012638","article-title":"hsCRP level and the risk of death or recurrent cardiovascular events in patients with myocardial infarction: a healthcare-based study","volume":"8","author":"Carrero","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hfc.2024.12.006_bib22","doi-asserted-by":"crossref","first-page":"102956","DOI":"10.1016\/j.ebiom.2020.102956","article-title":"Effects of tumour necrosis factor on cardiovascular disease and cancer: a two-sample Mendelian randomization study","volume":"59","author":"Yuan","year":"2020","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.006_bib23","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1210\/clinem\/dgac244","article-title":"Bariatric surgery-induced high-density lipoprotein functionality enhancement is associated with reduced inflammation","volume":"107","author":"Adam","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.006_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2014.12.033","article-title":"Leptin and incident cardiovascular disease: the multi-ethnic study of atherosclerosis (MESA)","volume":"239","author":"Martin","year":"2015","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.006_bib25","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2337\/dc08-1596","article-title":"Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals","volume":"32","author":"Lieb","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.hfc.2024.12.006_bib26","doi-asserted-by":"crossref","first-page":"100047","DOI":"10.1016\/j.deman.2021.100047","article-title":"Higher leptin levels are associated with coronary artery calcium progression: the multi-ethnic study of atherosclerosis (MESA)","volume":"6","author":"Varma","year":"2022","journal-title":"Diabet Epidemiol Manag"},{"issue":"18","key":"10.1016\/j.hfc.2024.12.006_bib27","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.jacc.2011.06.057","article-title":"Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease","volume":"58","author":"Wannamethee","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.006_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.ATV.0000048856.22331.50","article-title":"Association of hypoadiponectinemia with coronary artery disease in men","volume":"23","author":"Kumada","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.hfc.2024.12.006_bib29","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1161\/CIRCRESAHA.111.262493","article-title":"Adipose tissue biology and cardiomyopathy: translational implications","volume":"111","author":"Turer","year":"2012","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.006_bib30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.294.3.334","article-title":"Insulin resistance and risk of congestive heart failure","volume":"294","author":"Ingelsson","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.006_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11897-013-0133-0","article-title":"Cardiac lipotoxicity: molecular pathways and therapeutic implications","volume":"10","author":"Drosatos","year":"2013","journal-title":"Curr Heart Fail Rep"},{"issue":"14","key":"10.1016\/j.hfc.2024.12.006_bib32","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/01.CIR.0000012466.50373.E8","article-title":"Adaptation and maladaptation of the heart in diabetes: Part I: general concepts","volume":"105","author":"Taegtmeyer","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.006_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0008-6363(96)00245-3","article-title":"Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions","volume":"33","author":"Stanley","year":"1997","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.006_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbalip.2009.09.023","article-title":"Lipotoxicity in the heart","volume":"1801","author":"Wende","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/j.hfc.2024.12.006_bib35","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.bbalip.2016.02.016","article-title":"Lipid metabolism and signaling in cardiac lipotoxicity","volume":"1861","author":"D'Souza","year":"2016","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"6","key":"10.1016\/j.hfc.2024.12.006_bib36","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cmet.2012.04.006","article-title":"Lipid metabolism and toxicity in the heart","volume":"15","author":"Goldberg","year":"2012","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.006_bib37","doi-asserted-by":"crossref","first-page":"e1001485","DOI":"10.1371\/journal.pbio.1001485","article-title":"Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass","volume":"11","author":"Girousse","year":"2013","journal-title":"PLoS Biol"},{"issue":"10","key":"10.1016\/j.hfc.2024.12.006_bib38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tem.2011.05.001","article-title":"New insights into insulin resistance in the diabetic heart","volume":"22","author":"Gray","year":"2011","journal-title":"Trends Endocrinol Metab"},{"issue":"2\u20133","key":"10.1016\/j.hfc.2024.12.006_bib39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1388-1981(02)00342-6","article-title":"Lipoapoptosis: its mechanism and its diseases","volume":"1585","author":"Unger","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"10.1016\/j.hfc.2024.12.006_bib40","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1172\/JCI10947","article-title":"A\u00a0novel mouse model of lipotoxic cardiomyopathy","volume":"107","author":"Chiu","year":"2001","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.006_bib41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000441-200104000-00003","article-title":"Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome","volume":"321","author":"Alpert","year":"2001","journal-title":"Am J Med Sci"},{"issue":"25","key":"10.1016\/j.hfc.2024.12.006_bib42","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hfc.2024.12.006_bib43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.hfc.2024.12.006_bib44","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archinte.161.7.996","article-title":"Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study","volume":"161","author":"He","year":"2001","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.hfc.2024.12.006_bib45","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/ejhf.2064","article-title":"Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial","volume":"22","author":"Anker","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.006_bib46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.hfc.2024.12.006_bib47","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1161\/CIRCULATIONAHA.111.069518","article-title":"Effects of catecholamine stress on diastolic function and myocardial energetics in obesity","volume":"125","author":"Rider","year":"2012","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.hfc.2024.12.006_bib48","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.jacc.2021.04.003","article-title":"Pericardial fat and the risk of heart failure","volume":"77","author":"Kenchaiah","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hfc.2024.12.006_bib49","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/ehjci\/jeac101","article-title":"Pericardial adiposity is independently linked to adverse cardiovascular phenotypes: a CMR study of 42 598 UK Biobank participants","volume":"23","author":"Ardissino","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.hfc.2024.12.006_bib50","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/ejhf.1902","article-title":"Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease","volume":"22","author":"Packer","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.006_bib51","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jchf.2021.04.014","article-title":"Mechanistic insights of empagliflozin in nondiabetic patients with HFrEF: from the EMPA-TROPISM study","volume":"9","author":"Requena-Ibanez","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"10","key":"10.1016\/j.hfc.2024.12.006_bib52","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/heart.89.10.1127","article-title":"Cardiac function and obesity","volume":"89","author":"Vasan","year":"2003","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.006_bib53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/157340312803760749","article-title":"Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions","volume":"8","author":"Asghar","year":"2012","journal-title":"Curr Cardiol Rev"},{"issue":"6","key":"10.1016\/j.hfc.2024.12.006_bib54","doi-asserted-by":"crossref","first-page":"e12403","DOI":"10.1111\/cob.12403","article-title":"Obesity: a critical risk factor in the COVID-19 pandemic","volume":"10","author":"Kwok","year":"2020","journal-title":"Clin Obes"},{"issue":"23","key":"10.1016\/j.hfc.2024.12.006_bib55","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1001\/jama.284.23.3015","article-title":"Longitudinal study of moderate weight change and sleep-disordered breathing","volume":"284","author":"Peppard","year":"2000","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.hfc.2024.12.006_bib56","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0002-9149(03)00031-6","article-title":"Body composition and prognosis in chronic systolic heart failure: the obesity paradox","volume":"91","author":"Lavie","year":"2003","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.006_bib57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archinte.165.1.55","article-title":"The obesity paradox: body mass index and outcomes in patients with heart failure","volume":"165","author":"Curtis","year":"2005","journal-title":"Arch Intern Med"},{"issue":"2S","key":"10.1016\/j.hfc.2024.12.006_bib58","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.jmir.2024.02.010","article-title":"PET-determined myocardial perfusion and flow in coronary artery disease characterization","volume":"55","author":"Valenta","year":"2024","journal-title":"J\u00a0Med Imaging Radiat Sci"},{"issue":"5","key":"10.1016\/j.hfc.2024.12.006_bib59","first-page":"100933","article-title":"Coronary pathophysiology underlying the obesity Paradox\u2217","volume":"3","author":"Bui","year":"2024","journal-title":"JACC (J Am Coll Cardiol): Advances"},{"issue":"13","key":"10.1016\/j.hfc.2024.12.006_bib60","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/eurheartj\/ehad083","article-title":"Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox","volume":"44","author":"Butt","year":"2023","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.hfc.2024.12.006_bib61","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4330\/wjc.v7.i10.603","article-title":"\"Obesity paradox\" in coronary artery disease","volume":"7","author":"Akin","year":"2015","journal-title":"World J Cardiol"},{"issue":"8323","key":"10.1016\/j.hfc.2024.12.006_bib62","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0140-6736(83)92189-X","article-title":"The relation of coronary disease, stroke, and mortality to weight in youth and in middle age","volume":"1","author":"Rhoads","year":"1983","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.006_bib63","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/oxfordjournals.aje.a009275","article-title":"Hypothesis concerning the U-shaped relation between body mass index and mortality","volume":"146","author":"Allison","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.006_bib64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/EDE.0b013e31828c776c","article-title":"The \u201cobesity paradox\u201d explained","volume":"24","author":"Banack","year":"2013","journal-title":"Epidemiology"},{"key":"10.1016\/j.hfc.2024.12.006_bib65","series-title":"Collider bias in observational studies: consequences for medical research. Part 30 of a series on evaluation of scientific publications","author":"T\u00f6nnies","year":"2022"},{"issue":"13","key":"10.1016\/j.hfc.2024.12.006_bib66","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jama.2022.1820","article-title":"Collider bias","volume":"327","author":"Holmberg","year":"2022","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.hfc.2024.12.006_bib67","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/eurjpc\/zwac187","article-title":"Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation","volume":"29","author":"Lopez-Jimenez","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.hfc.2024.12.006_bib68","doi-asserted-by":"crossref","first-page":"e072686","DOI":"10.1136\/bmj-2022-072686","article-title":"Effectiveness and safety of drugs for obesity","volume":"384","author":"Henderson","year":"2024","journal-title":"BMJ"},{"issue":"7892","key":"10.1016\/j.hfc.2024.12.006_bib69","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41586-021-04211-w","article-title":"Structure and mechanism of the SGLT family of glucose transporters","volume":"601","author":"Han","year":"2022","journal-title":"Nature"},{"issue":"7892","key":"10.1016\/j.hfc.2024.12.006_bib70","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41586-021-04212-9","article-title":"Structural basis of inhibition of the human SGLT2\u2013MAP17 glucose transporter","volume":"601","author":"Niu","year":"2022","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.hfc.2024.12.006_bib71","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.2337\/dc15-0642","article-title":"Sodium-glucose cotransporter inhibitors: effects on renal and intestinal glucose transport: from bench to bedside","volume":"38","author":"Mudaliar","year":"2015","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.006_bib72","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11739-024-03532-8","article-title":"Sodium\u2013glucose cotransporter-2 inhibitors in heart failure patients across the range of body mass index: a systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Adamou","year":"2024","journal-title":"Intern Emerg Med"},{"issue":"6","key":"10.1016\/j.hfc.2024.12.006_bib73","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s40495-020-00236-3","article-title":"SGLT2 inhibitors and the mechanisms involved in weight loss","volume":"6","author":"Feder","year":"2020","journal-title":"Current Pharmacology Reports"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.006_bib74","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ejhf.2728","article-title":"Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from <scp>EMPEROR-Reduced<\/scp>","volume":"25","author":"Anker","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.hfc.2024.12.006_bib75","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-8587(24)00102-5","article-title":"Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis","volume":"12","author":"Usman","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"36","key":"10.1016\/j.hfc.2024.12.006_bib76","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.hfc.2024.12.006_bib77","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.006_bib78","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metabol"},{"key":"10.1016\/j.hfc.2024.12.006_bib79","doi-asserted-by":"crossref","first-page":"101213","DOI":"10.1016\/j.eclinm.2021.101213","article-title":"Association of glucagon-like peptide 1 analogs and agonists administered for obesity with weight loss and adverse events: a systematic review and network meta-analysis","volume":"42","author":"Vosoughi","year":"2021","journal-title":"eClinicalMedicine"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.006_bib80","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.eprac.2023.11.007","article-title":"Efficacy and safety of glucagon-like peptide-1 receptor agonists on body weight and cardiometabolic parameters in individuals with obesity and without diabetes: a systematic review and meta-analysis","volume":"30","author":"Ansari","year":"2024","journal-title":"Endocr Pract"},{"key":"10.1016\/j.hfc.2024.12.006_bib81","doi-asserted-by":"crossref","first-page":"e076410","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"issue":"9701","key":"10.1016\/j.hfc.2024.12.006_bib82","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","article-title":"Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study","volume":"374","author":"Astrup","year":"2009","journal-title":"Lancet"},{"issue":"10148","key":"10.1016\/j.hfc.2024.12.006_bib83","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(18)31773-2","article-title":"Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial","volume":"392","author":"O'Neil","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.hfc.2024.12.006_bib84","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.hfc.2024.12.006_bib85","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.006_bib86","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.hfc.2024.12.006_bib87","doi-asserted-by":"crossref","first-page":"102475","DOI":"10.1016\/j.eclinm.2024.102475","article-title":"Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial","volume":"69","author":"Jensen","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"12","key":"10.1016\/j.hfc.2024.12.006_bib88","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.hfc.2024.12.006_bib89","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.006_bib90","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","article-title":"Anti-obesity drug discovery: advances and challenges","volume":"21","author":"Muller","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.hfc.2024.12.006_bib91","article-title":"What is the pipeline for future medications for obesity?","author":"Melson","year":"2024","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.006_bib92","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.006_bib93","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/dom.15318","article-title":"Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis","volume":"26","author":"Hankosky","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.hfc.2024.12.006_bib94","doi-asserted-by":"crossref","first-page":"e078242","DOI":"10.1136\/bmj-2023-078242","article-title":"Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study","volume":"385","author":"Simms-Williams","year":"2024","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.006_bib95","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/dme.14215","article-title":"Medical and surgical management of obesity and diabetes: what's new?","volume":"37","author":"Ammori","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/j.hfc.2024.12.006_bib96","doi-asserted-by":"crossref","first-page":"e071027","DOI":"10.1136\/bmj-2022-071027","article-title":"Long term outcomes of metabolic\/bariatric surgery in adults","volume":"383","author":"Courcoulas","year":"2023","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.hfc.2024.12.006_bib97","doi-asserted-by":"crossref","first-page":"e13602","DOI":"10.1111\/obr.13602","article-title":"Microvascular complications of obesity and diabetes-Role of bariatric surgery","volume":"24","author":"Bashir","year":"2023","journal-title":"Obes Rev"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.006_bib98","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11695-022-06332-1","article-title":"2022 American society of metabolic and bariatric surgery (ASMBS) and international federation for the surgery of obesity and metabolic disorders (IFSO) indications for metabolic and bariatric surgery","volume":"33","author":"Eisenberg","year":"2023","journal-title":"Obes Surg"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.006_bib99","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1186\/s12889-021-12009-8","article-title":"The association between obesity and quality of life: a retrospective analysis of a large-scale population-based cohort study","volume":"21","author":"Stephenson","year":"2021","journal-title":"BMC Publ Health"},{"issue":"15","key":"10.1016\/j.hfc.2024.12.006_bib100","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.3390\/ijerph19159078","article-title":"Quality of life after bariatric surgery-A systematic review","volume":"19","author":"Sierzantowicz","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.006_bib101","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sjostrom","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.006_bib102","first-page":"e23340","article-title":"The impact of bariatric surgery on cardiovascular risk factors and outcomes: a systematic review","volume":"14","author":"Srinivasan","year":"2022","journal-title":"Cureus"},{"issue":"20","key":"10.1016\/j.hfc.2024.12.006_bib103","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/eurheartj\/ehac071","article-title":"Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis","volume":"43","author":"van Veldhuisen","year":"2022","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.006_bib104","doi-asserted-by":"crossref","first-page":"e237188","DOI":"10.1001\/jamanetworkopen.2023.7188","article-title":"Cardiovascular outcomes and mortality after bariatric surgery in patients with nonalcoholic fatty liver disease and obesity","volume":"6","author":"Krishnan","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"28","key":"10.1016\/j.hfc.2024.12.006_bib105","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1093\/eurheartj\/ehaa069","article-title":"Effect of bariatric surgery on long-term cardiovascular outcomes: a nationwide nested cohort study","volume":"41","author":"Moussa","year":"2020","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.006_bib106","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41366-023-01412-3","article-title":"The effects of bariatric surgery on cardiac function: a systematic review and meta-analysis","volume":"48","author":"Sargsyan","year":"2024","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.hfc.2024.12.006_bib107","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fcvm.2019.00094","article-title":"Effects of bariatric surgery on cardiovascular disease: a concise update of recent advances","volume":"6","author":"Kuno","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hfc.2024.12.006_bib108","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.resp.2019.05.007","article-title":"Effect of weight loss via bariatric surgery for class III obesity on exertional breathlessness","volume":"266","author":"Mainra","year":"2019","journal-title":"Respir Physiol Neurobiol"},{"issue":"9","key":"10.1016\/j.hfc.2024.12.006_bib109","doi-asserted-by":"crossref","first-page":"694","DOI":"10.7326\/M19-3925","article-title":"Association between bariatric surgery and all-cause mortality: a population-based matched cohort study in a universal health care system","volume":"173","author":"Doumouras","year":"2020","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.hfc.2024.12.006_bib110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11883-015-0551-4","article-title":"All-cause and cause-specific mortality associated with bariatric surgery: a review","volume":"17","author":"Adams","year":"2015","journal-title":"Curr Atheroscler Rep"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.006_bib111","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1038\/s41591-024-03052-0","article-title":"Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure","volume":"30","author":"Wolff Sagy","year":"2024","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.hfc.2024.12.006_bib112","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s11695-016-2294-x","article-title":"Pregnancy following bariatric surgery-medical complications and management","volume":"26","author":"Narayanan","year":"2016","journal-title":"Obes Surg"},{"issue":"11","key":"10.1016\/j.hfc.2024.12.006_bib113","doi-asserted-by":"crossref","first-page":"e13087","DOI":"10.1111\/obr.13087","article-title":"British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update","volume":"21","author":"O'Kane","year":"2020","journal-title":"Obes Rev"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.006_bib114","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2468-1253(20)30302-2","article-title":"Adaptations in gastrointestinal physiology after sleeve gastrectomy and Roux-en-Y gastric bypass","volume":"6","author":"Steenackers","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.hfc.2024.12.006_bib115","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/CIRCULATIONAHA.119.045409","article-title":"Altered hemodynamics and end-organ damage in heart failure: impact on the lung and kidney","volume":"142","author":"Verbrugge","year":"2020","journal-title":"Circulation"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624001028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624001028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:25:29Z","timestamp":1762550729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713624001028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1551713624001028"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2024.12.006","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity Management for Patients with Coronary Artery Disease and Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2024.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}